- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07419555
Étude Belge de la Fonction Pulmonaire (AIRCAST)
Étude Belge de la Fonction Pulmonaire : Analyse Longitudinale Personnalisée de la Fonction Pulmonaire comme Marqueur de Progression de la Maladie
Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns.
A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
The objective of this study is to explore the clinical value of models predicting longitudinal lung function patterns in individuals with chronic respiratory diseases across Belgium.
- The investigators will assess the accuracy of individualised lung function prediction models in a multicentre lung function dataset with prospective clinical and lung function follow-up.
- The investigators will evaluate important health outcomes, step-up in care, patient-reported outcomes in individuals identified with an expected and unexpected observed trajectory as compared to the predicted population and individualised trajectory.
The hypothesis is that patients with an unexpected decline in lung function will have worse health outcomes, such as a higher mortality rate and more hospitalisations, compared to patients with an expected lung function pattern. The investigators hypothesise to observe better health outcomes and lower mortality rates in patients with an unexpectedly positive lung function evolution compared to patients with an expected negative lung function pattern.
Individuals will be recruited from 4 Belgian Hospitals (UZ Leuven, UZ Antwerpen, AZ Delta, ZOL Genk). Based on the annual rate of pulmonary function testing in these hospitals, a sample size of 1.000 participants per centre is anticipated within one year of inclusions, resulting in a total sample size of 4.000 patients.
All available historical lung function data of included individuals will be retrieved from the individuals medical file. Additionally, the individual will be prospectively followed for 2 years where all lung function data will be collected.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Marieke Wuyts
- Numéro de téléphone: 016 34 31 59
- E-mail: marieke.wuyts@kuleuven.be
Lieux d'étude
-
-
-
Edegem, Belgique, 2650
- Recrutement
- UZ Antwerpen
-
Contact:
- Therese Lapperre
- Numéro de téléphone: 0032 3 821 5089
- E-mail: therese.lapperre@uza.be
-
Chercheur principal:
- Therese Lapperre
-
Sous-enquêteur:
- Kevin De Soomer
-
Genk, Belgique, 3600
- Recrutement
- Ziekenhuis Oost-Limburg
-
Contact:
- David Ruttens
- Numéro de téléphone: 0032 89 80 52 00
- E-mail: david.ruttens@zol.be
-
Chercheur principal:
- David Ruttens
-
Sous-enquêteur:
- Maarten Criel
-
Ghent, Belgique
- Recrutement
- UZ Gent
-
Chercheur principal:
- Eric Derom
-
Contact:
- Eric Derom
- Numéro de téléphone: 0032 9 332 23 42
- E-mail: Eric.Derom@uzgent.be
-
Sous-enquêteur:
- Lies Lahousse
-
Leuven, Belgique, 3000
- Recrutement
- UZ Leuven
-
Chercheur principal:
- Wim Janssens
-
Contact:
- Marieke Wuyts
- Numéro de téléphone: 016 34 31 59
- E-mail: marieke.wuyts@kuleuvne.be
-
Roeselare, Belgique, 8800
- Recrutement
- AZ Delta
-
Chercheur principal:
- Ingel Demedts
-
Contact:
- Ingel Demedts
- Numéro de téléphone: 0032 51 23 41 16
- E-mail: ingel.demedts@azdelta.be
-
Sous-enquêteur:
- Bernard Bouckaert
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Chronic respiratory diseases
La description
Inclusion Criteria:
- Above 18 years old
- Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals
- Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline
- Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion
- Planned routine follow-up within standard clinical care in one of the participating hospitals
Exclusion Criteria:
- Patients who have had a lung transplantation
- Patients not being able to give consent to participate
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Accuracy of lung function predictions (FEV1)
Délai: at 1 and 2-year follow-up
|
Proportion of correct and incorrect FEV1 predictions compared to the observed measure |
at 1 and 2-year follow-up
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Differences in clinical outcomes between correct and incorrect lung function predictions (FEV1)
Délai: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FEV1 on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care |
at 1 and 2-year follow-up
|
|
Accuracy of lung function predictions
Délai: at 1 and 2-year follow-up
|
Proportion of correct and incorrect lung function predictions (FVC, TLC, RV/TLC, DLCO) compared to the observed measure |
at 1 and 2-year follow-up
|
|
Differences in clinical outcomes between correct and incorrect lung function predictions
Délai: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FVC, TLC, RV/TLC, DLCO on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care) |
at 1 and 2-year follow-up
|
|
Identifying the minimal needed to make predictions
Délai: after 2 years
|
Minimal number of tests/length of follow-up required for optimal predictions |
after 2 years
|
|
Performance of ML-based predictions compared to linear regression analysis
Délai: at 1 and 2-year follow-up
|
Comparison of the ML-based predictions for individual and population lung function changes with predictions based on linear regression on individual historical data |
at 1 and 2-year follow-up
|
|
Overall description of population
Délai: baseline, 1 and 2-year follow-up
|
Sociodemographic information, health status, comorbidities, frailty, disease labels, interventions and prognosis of individuals with a chronic respiratory disease |
baseline, 1 and 2-year follow-up
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Wim Janssens, UZ/KU Leuven
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- S70923
- C2M25045 (Autre subvention/numéro de financement: Internal funding KULeuven)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .